• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Does ivabradine really limit dobutamine-induced tachycardia in stable heart failure patients: parallax in significance.

作者信息

Mert Kadir Uğur, Mert Gurbet Özge, Başaran Ozcan, Biteker Murat

机构信息

Muğla Sıtkı Koçman University, Faculty of Medicine, Department of Cardiology, Turkey.

Muğla Sıtkı Koçman University, Faculty of Medicine, Department of Cardiology, Turkey.

出版信息

Int J Cardiol. 2014 Dec 15;177(2):726. doi: 10.1016/j.ijcard.2014.10.021. Epub 2014 Oct 12.

DOI:10.1016/j.ijcard.2014.10.021
PMID:25456579
Abstract
摘要

相似文献

1
Does ivabradine really limit dobutamine-induced tachycardia in stable heart failure patients: parallax in significance.伊伐布雷定真的能限制稳定型心力衰竭患者多巴酚丁胺诱发的心动过速吗：意义上的差异。
Int J Cardiol. 2014 Dec 15;177(2):726. doi: 10.1016/j.ijcard.2014.10.021. Epub 2014 Oct 12.
2
Response to letter: "Does Ivabradine really limit dobutamine-induced tachycardia in stable heart failure patients: parallax in significance".
Int J Cardiol. 2015 Jan 20;179:217. doi: 10.1016/j.ijcard.2014.11.069. Epub 2014 Nov 6.
3
Ivabradine: a promising drug in cardiogenic shock to prevent the undesirable sinus tachycardia induced by dobutamine?伊伐布雷定：一种有望用于心源性休克以预防多巴酚丁胺诱发的不良窦性心动过速的药物？
Int J Cardiol. 2015 Jan 15;178:308-10. doi: 10.1016/j.ijcard.2014.09.106. Epub 2014 Sep 28.
4
Hemodynamic effects of Ivabradine in addition to dobutamine in patients with severe systolic dysfunction.伊伐布雷定联合多巴酚丁胺对重度收缩功能不全患者的血流动力学影响
Int J Cardiol. 2014 Sep 20;176(2):450-5. doi: 10.1016/j.ijcard.2014.07.093. Epub 2014 Aug 1.
5
Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure.伊伐布雷定对多巴酚丁胺诱发的急性心力衰竭患者窦性心动过速的影响。
Clin Res Cardiol. 2009 Aug;98(8):513-5. doi: 10.1007/s00392-009-0038-9. Epub 2009 Jun 23.
6
Haemodynamic response during low-dose dobutamine infusion in patients with chronic systolic heart failure: comparison of echocardiographic and invasive measurements.慢性收缩性心力衰竭患者低剂量多巴酚丁胺输注期间的血液动力学反应：超声心动图与有创测量的比较。
Eur Heart J Cardiovasc Imaging. 2013 Jul;14(7):659-67. doi: 10.1093/ehjci/jes234. Epub 2012 Nov 6.
7
Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (from the SHIFT study).依伐布雷定治疗严重慢性收缩性心力衰竭患者的疗效和安全性（来自 SHIFT 研究）。
Am J Cardiol. 2014 Feb 1;113(3):497-503. doi: 10.1016/j.amjcard.2013.10.033. Epub 2013 Nov 9.
8
Ivabradine for systolic heart failure.
JAAPA. 2018 Mar;31(3):52-54. doi: 10.1097/01.JAA.0000530305.69021.02.
9
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.依伐布雷定降低心力衰竭患者心率对结局的影响：β受体阻滞剂剂量是否有影响？SHIFT（伊伐布雷定治疗收缩性心力衰竭试验）研究的结果。
J Am Coll Cardiol. 2012 May 29;59(22):1938-45. doi: 10.1016/j.jacc.2012.01.020.
10
Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial.血管加压素V2受体阻滞剂托伐普坦对有症状心力衰竭和收缩功能障碍患者的急性血流动力学影响：一项国际、多中心、随机、安慰剂对照试验
J Am Coll Cardiol. 2008 Nov 4;52(19):1540-5. doi: 10.1016/j.jacc.2008.08.013.